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Abstract
Background: The prevalence of H. pylori is as high as 60–70% in Chinese population. Although
duodenal ulcer and gastric cancer are both caused by H. pylori, they are at opposite ends of the
spectrum and as such are considered mutually exclusive. Duodenal ulcer promoting (dupA) gene
was reported to be associated with duodenal ulcer development. The aim of this study was to
determine the prevalence of dupA gene of Helicobacter pylori in patients with various gastroduodenal
diseases and to explore the association between the gene and other virulence factors.
Methods: H. pylori were isolated from gastric biopsies of patients with chronic gastritis, duodenal
ulcer (DU), gastric ulcer (GU), or non-cardia gastric carcinoma. The dupA, cagA, vacA, iceA and
babA2 genotypes were determined by polymerase chain reaction. Histological features of gastric
mucosal biopsy specimens were graded based on the scoring system proposed by the updated
Sydney system. IL-1β polymorphism was investigated using restriction fragment length
polymorphism.
Results: Isolates from 360 patients including 133 with chronic gastritis, 101 with DU, 47 with GU,
and 79 with non-cardia gastric carcinoma were examined. The dupA gene was detected in 35.3%
(127/360) and the prevalence DU patients was significantly greater than that in gastric cancer or
GU patients (45.5% vs. 24.1% and 23.4%, P < 0.05). Patients infected with dupA-positive strains had
higher scores for chronic inflammation compared to those with dupA-negative strains (2.36 vs. 2.24,
p = 0.058). The presence of dupA was not associated with the cagA, vacA, iceA and babA 2 genotypes
or with IL-1β polymorphisms.
Conclusion: In China the prevalence of dupA gene was highest in DU and inversely related to GU
and gastric cancer.
Background
The morbility and mortality of gastric cancer rank the
third in Chinese population and it accounts for around
0.3 million deaths per year. There is considerable interest
in identifying virulence factors that are Helicobacter pylori
disease specific (eg, related to duodenal ulcer and not gas-
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tric cancer). Several virulence factors such as the cag path-
ogenicity island, vacA, oipA and babA have been described
and have been associated with an increase in the risk of
both gastric cancer and duodenal ulcer disease [1-4]. They
have also been associated with an increase in mucosal
inflammation which is thought to underlie both duode-
nal ulcers and gastric cancer. Duodenal ulcer is associated
with corpus sparing gastritis and gastric cancer with cor-
pus atrophy and are clinically mutually exclusive diseases.
One problem that has possibly complicated identification
of definite disease-specific H. pylori virulence factors is the
considerable geographic diversity in the prevalence of H.
pylori virulence factors. For example, in some regions, (ie,
East Asia) the vast majority of strains have similar if not
identical patterns of virulence factors such that potentially
important factors can best be identified in regions where
there is considerable diversity among strains. For exam-
ple, the associations between the cag pathogenicity island,
vacA, oipA and babA and enhanced mucosal inflamma-
tion, gastric cancer and peptic ulcer were identified and
confirmed in Western countries where there is considera-
ble strain diversity [5-9]. Polymorphism of interleukin-1β
was reported to be an important host factor that increases
the risk gastric cancer [10,11].
The duodenal ulcer promoting (dupA) gene was the first
putative disease specific marker whose association was
described using strains obtained from in both Asian
(Japan and Korea) and Western (Colombia) regions [12].
dupA  is though to be a vir  homologue and the gene
encompasses the sequences jhp917 and jhp918 as describe
in strain J99. The original description of dupA reported
that its presence was associated with increased mucosal
neutrophil infiltration and its presence was inversely
related to mucosal atrophy and gastric cancer. The aims of
this study were to test the hypothesis regarding the associ-
ation of dupA with the clinical outcome in a different pop-
ulation (ie, Chinese patients) as well as to test whether
there were associations between dupA  and previously
described virulence factors or with proinflammatory inter-
leukin-1β (IL-1β) polymorphisms.
Methods
Patients
Inclusion criteria included patients with documented H.
pylori infection as evidence by positive H. pylori culture
who underwent gastric endoscopy with biopsy specimens
for H. pylori culture between January 2006 to August 2007
in the Department of Gastroenterology, Shanghai Renji
Hospital, Shanghai, China. The patients involved were
from 23 cities of China. All patients had simple H. pylori
gastritis or a clinical H. pylori-related disease including:
duodenal ulcer (DU), gastric ulcer (GU) or non-cardiac
gastric adenocarcinoma. Simple H. pylori gastritis was
defined as the presence of typical histological inflamma-
tion of gastric mucosa without peptic ulcer, gastric cancer
or esophageal disease. Duodenal ulcers and gastric ulcers
were identified endoscopically as active ulcers or ulcer
scars. Exclusion criteria included negative results for cul-
ture, the presence of both duodenal and gastric ulcers or
prior treatment for H. pylori infection. Patients with other
primary malignancies, inflammatory diseases such as
rheumatoid arthritis, or prior gastric surgery were also
excluded. Written informed consent was obtained from
all patients and the protocol was approved by the Institu-
tional ethics committee of the Shanghai Renji Hospital
based on the Helsinki Declaration.
Biopsy protocol
Three biopsy specimens were taken from the greater cur-
vature of the antrum in patients of gastritis, DU and GU.
One specimen was used for H. pylori culture and two for
histological examination. For gastric cancer and GU group
one normal-appearing biopsy was taken culture and other
3 or 4 biopsies for diagnosis.
H. pylori culture from biopsy specimens
The biopsies was inoculated onto brain heart infusion
agar plates (Difco Laboratories, Detroit, USA) supple-
mented with 7% sheep blood, vancomycin (10 mg/mL),
trimethoprim lactate (5 mg/L), amphoteracin-B (5 mg/
mL) and of polymixin-B (2500 units/mL) and incubated
in a microaerobic atmosphere (10%CO2, 85%N2, 5%O2)
at 37°C for 5–7 days with 95% humidity. The organisms
were identified as H. pylori by Gram staining, colony mor-
phology and positive oxidase, catalase and urease reac-
tions. Bacteria were sub-cultured using the same
conditions.
Histological evaluation
Gastric mucosal biopsy specimens were fixed in 10% buff-
ered formalin, embedded in paraffin, cut in sequential 4-
μm sections, stained with Haematoxylin & Eosin and
modified Giemsa stain. One experienced pathologist
blinded to the patient's clinical diagnosis examined the
samples. Each specimen was scored for chronic inflamma-
tion, neutrophil infiltration, intestinal metaplasia and
atrophy. Histological features were graded with the visual
analog scale system graded from 0 (absent/normal) to 3
(maximal intensity) according to the scheme proposed by
the updated Sydney system [13]. Each biopsy site was
scored individually and the median score was determined
for the all biopsy sites.
DNA Extraction and PCR amplification
Bacterial chromosomal DNA was isolated from confluent
plate cultures expanded from a single colony using the
QIAamp Tissue kit (QIAGEN Inc. Santa Clarita, CA)
according to the manufacturer's instructions. The isolatedBMC Gastroenterology 2008, 8:49 http://www.biomedcentral.com/1471-230X/8/49
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DNA was used as the template for PCR amplification. The
16S rRNA gene was amplified to confirm the presence of
the isolated H. pylori strains. For analyses of the presence
of target genes, dupA, cagA, babA2, iceA and vacA geno-
types, H. pylori DNA were amplified using specific oligo-
nucleotide primers described previously [Table 1] [14-
18]. Primers of jhp0917 yielded a fragment of approxi-
mately 307 bp and primers of jhp0918 yielded a fragment
of approximately 276 bp. PCR amplification was per-
formed with a DNA Engine (MJ Research Inc., Watertown,
Mass.) for 35 cycles consisting of 1 min at 95°C, 1 minute
at 52°C and 1 minute at 72°C. The final cycle included a
7 min extension step to ensure full extension of the PCR
products. The products of amplification were subse-
quently electrophoresed in 1.5% agarose gel stained with
ethidium bromide to visualize the presence of amplified
genes.  H. pylori strain 26695 (ATCC700392) and J99
(ATCC700824) were used as negative and positive con-
trols. The presence of dupA gene was defined as positive
PCR results for both jhp0917 (product of 307 bp) and
jhp0918 (276 bp product). If the PCR results yielded neg-
ative results, the isolate was considered negative for dupA.
IL-1β polymorphism
The genomic DNA was purified from 5 ml samples of
peripheral bloods using Wizard Genomic DNA Purifica-
tion kit (Promega) according to the manufacture's instruc-
tion. The polymorphisms (IL-1β-31 and IL-1β-511) were
investigated using restriction fragment length polymor-
phism analysis of polymerase chain reaction products as
previously studied [19]. PCR products were digested by
restriction endonucleases (Alul for IL-1β-31 and Ava1 for
IL-1β-511) and visualized by electrophoresis on a 2.5%
agarose gel stained with 0.1% ethidium bromide.
Data analysis
Chi-squire test and Fisher's exact test was used for univar-
iate analysis. The significance of differences in histological
features between dupA positive and negative groups was
determined by comparing individual grades using the
Mann-Whitney U test. P < 0.05 was taken to denote signif-
icance.
Results
H. pylori isolates were obtained from 360 patients (235
men and 125 women; mean age of 53 years; range 17–90
years). The proportion of men was higher in the GU than
in other three groups (p = 0.03) and the mean age of the
patients with DU was lower than those with GU gastric
cancer or gastritis (p = 0.03) (Table 2).
Detection of the dupA gene and clinical manifestations
Overall, the dupA gene was present in 35.3% (127/360,
95% confidence interval (CI), 30.3–40.2%) of H. pylori
strains isolated and the prevalence of the dupA gene was
significantly higher in strains from DU (46/101, 45.5%,
95%CI, 38.2–55.2%) compared to those from gastric can-
cer (19/79, 24.1%, 95%CI, 14.6–33.5%) or GU (11/47,
23.4%, 95%CI, 11.3–35.5%) (P < 0.05 for both) confirm-
ing the original observation that dupA was related to DU
and protective against gastric cancer (Figure 1). Fifty-one
(38.3%, 95%CI, 30–45.6%) of the 133 patients with gas-
tritis had dupA-positive strains which was higher than
among those with gastric cancer but the difference did not
reach statistically significance (P = 0.06). There is no sig-
nificant difference between DU group and gastritis group
(P = 0.2). The result also showed that the presence of the
jhp0917  and  jhp0918  genes was strongly linked (P  <
0.001). Nine strains (2.5%) possessed jhp0917 positive/
jhp0918  negative genotype and were classified as dupA
negative. A jhp0917 negative/jhp0918 positive genotype
strain was not detected.
Association of dupA gene with histological findings
We compared the relationship between the present of
dupA and the degree of chronic inflammation, neutrophil
infiltration, atrophy and intestinal metaplasia in the
antrum in the different groups except gastric cancer
Table 1: Primers used in the study
Gene Primer Sequences Reference
16S rRNA 5'-GCGCAATCAGCGTCAGGTAATG-3' 5'-GCTAAGAGATCAGCCTATGTCC-3' 14
cagA-3'region 5'-ACC CTA GTC GGT AAT GGG TTA-3' 5'-GTA ATT GTC TAG TTT CGC-3' 15
babA2 5'-AAT CCA AAA AGG AGA AAA AGT ATG AAA-3' 5'-TGT TAG TGA TTT CGG TGT AGG ACA-3' 17
iceA1 5'-GTG TTT TTA ACC AAA GTA TC-3' 5'-CTA TAG CCA STY TCT TTG CA-3' 18
iceA2 5'-GTT GGG TAT ATC ACA ATT TAT-3' 5'-TTR CCC TAT TTT CTA GTA GGT-3' 18
vacAs1a 5'-GTC AGC ATC ACA CCG CAA C-3' 5'-CTG CTT GAA TGC GCC AAA C-3' 16
vacAs1b 5'-AGC GCC ATA CCG CAA GAG-3' 5'-CTG CTT GAA TGC GCC AAA C-3' 16
vacAs2 5'-GCT AAC ACG CCA AAT GAT CC-3' 5'-CTG CTT GAA TGC GCC AAA C-3' 16
vacAm1 5'-GGT CAA AAT GCG GTC ATG G-3' 5'-CCA TTG GTA CCT GTA GAA AC-3' 16
vacAm2 5'-GGA GCC CCA GCA AAC ATT G-3' 5'-CAT AAC TAG CGC CTT GCA C-3' 16
jhp0917 5'-TGG TTT CTA CTG ACA GAG CGC-3' 5'-AAC ACG CTG ACA GGA CAA TCT CCC-3' 12
jhp0918 5'-CCT ATA TCG CTA ACG CGC TCG C-3' 5'-AAG CTG AAG CGT TTG TAA CG-3' 12BMC Gastroenterology 2008, 8:49 http://www.biomedcentral.com/1471-230X/8/49
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patients. Mann-Whitney U test showed that although
patients infected with dupA-positive strains had higher
scores for chronic inflammation compared to those with
dupA-negative strains (2.36 vs. 2.24, p = 0.058), but the
difference did not reach statistical significance (Table 3).
The prevalence of the dupA gene was also independent of
the scores of other histological variables including antral
neutrophil infiltration, atrophy and intestinal metaplasia.
Association with other virulence factors
The only type of vacA signal sequence detected was s1a.
Most (98%) strains were cagA-positive and 93% strains
were vacA s1 genotype. The positive rate of vacA m1, vacA
m2, iceA1, iceA2 and babA 2 of the 360 strains was 27%,
69%, 90%, 16%, and 64%, respectively (Table 4). The
presence of dupA was not associated with any other viru-
lence factors (P > 0.50 for all groups).
Association of dupA gene with IL-1β polymorphism
There were no significant differences in IL-1β genotype
distribution between patients with dupA positive strains
and those with negative strains (P = 0.50 for the patients
with IL-1β-31 C carriers and P = 0.68 for IL-1β-511 T car-
riers).
Discussion
Although DU and gastric cancer are both caused by H.
pylori, they are at opposite ends of the spectrum and as
such are considered mutually exclusive. DU is associated
with sparing of the gastric corpus and high acid secretion
whereas gastric cancer is associated with an atrophic pan-
gastritis and low to absent acid secretion [20-22]. These
different manifestations of the infection are thought to
relate to as yet unexplained interactions between host and
environmental factors and with bacteria virulence. Cur-
rent virulence determinants including the cag-pathogenic-
ity island, OipA, and BabA individually and together have
been associated with an increased risk of ulcer or gastric
cancer, however none has consistently shown specificity
related to a specific pattern of gastritis or disease outcome.
The dupA gene is thought to be a homolog of the virB4
gene and is located in plasticity region of the H. pylori
genome. Originally it was reported to be rare (9%) among
patients with gastric cancer and common (42%) among
patients with duodenal ulcer. As such, it appeared to be a
marker for the presence of antral predominant gastritis
and "protective" against the development of atrophic pan-
gastritis. Using the same primers and primers of their own
design, Arachchi et al. [23] confirmed that the dupA gene
was present in approximately the same percentage of H.
pylori  strains isolated from DU patients (37%) in an
Indian population as originally described [10]. They did
not study patients with gastric cancer. A study in Brazilian
adults [24] reported the dupA gene was present in 87% of
patients with either DU or gastric cancer. They used their
own primer set based on the sequences of Brazilian strains
as well as the original primer sets. They subsequently
reported identified two polymorphisms, an adenine dele-
tion at the position 1311 and/or an adenine insertion
after the position 1426 of the dupA gene in their isolates
that led to different results [25]. They reported that the
presence of wild dupA was significantly lower in gastric
cancer (50%) than in gastritis (70%) or DU (78%).
Finally, Argent et al. used the originally described primers
and several other primer sets to examined H. pylori strains
collected from Belgium (135 samples), South Africa (46
samples), China (31 samples) and the United States (46
samples) and reported that the prevalence of dupA gene
was 50.6% of H. pylori strains isolated from DU patients
and 71.1% from gastric cancer patients [26]. In this study,
we evaluated Chinese isolates using the originally
described primer sets. All patients had the typical East Asia
type H. pylori genotype (ie, cagA+ve/vacA s1+ve) and dupA
was present in 46% of strains from DU compared to 24%
of patients with gastric cancer this confirming the original
observations that dupA was commonly found in strains
from patients with DU and infrequent among those with
gastric cancer. The overall prevalence of dupA in Chinese
isolates in study of Argent et al. was 32.3% which is simi-
Table 2: Patients' characteristics in the study
Men (%) Mean age (range, years)
DU (n = 101) 59 (58%) 41 (17–72)
Gastritis (n = 133) 80 (61%) 59 (18–81)
Gastric cancer (n = 79) 54(68%) 59 (34–90)
GU (n = 47) 42 (89%) 58 (32–83)
Prevalence of the dupA gene and clinical outcomes Figure 1
Prevalence of the dupA gene and clinical outcomes.
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lar to our result (35.3%). They only had one strain from a
Chinese gastric cancer patient such that the DU: gastric
cancer ratio could not be examined. In their study the
results with China were lower than other three Western
countries (43.5 to 84.8%). The difference between our
studies and those of Argent et al. may be technical or relate
to geographic variations circulation strains or difference in
the definitions of patient groups [26]. In addition, we
extended prior observations by showing that there was no
relationship between dupA and previously proposed viru-
lence factors (cagA, vacA,, iceA and babA2) or with host IL-
1β polymorphisms.
Based on studies by the current author showing that pres-
ence of dupA appears to be associated with the absence of
severe corpus gastritis or alternately with antral predomi-
nant gastritis, one can propose studies to directly test the
hypothesis that dupA is associated with a particular pat-
tern of gastritis. For example, the group of patients with H.
pylori gastritis alone contains subgroups of patients some
of whom will develop DU (ie, retain the antral predomi-
nant pattern), some destined to develop panatrophic gas-
tritis and gastric cancer, and some who do neither. Thus,
one would expect the presence of dupA to be inversely
related to the severity of corpus gastritis. Unfortunately,
the design of the current study did not allow us to test this
hypothesis as we did not systematically collect corpus
mucosal samples from the gastritis only group and we
were only able to compare the severity of antral gastritis in
relation to the presence of dupA. Patients infected with
dupA-positive strains had higher scores for chronic inflam-
mation compared to those with dupA-negative strains but
the difference missed achieving statistical significance (p =
0.058). Initially dupA was identified in strain J99 where
the gene was disrupted. Studies from Brazil have identi-
fied another truncation site [25] suggesting that PCR
determination of functional dupA status may sometime
provide misleading results. Interpretation of future stud-
ies would be improved if the presence of the DupA pro-
tein can be directly assessed as that would eliminate false
positive PCR results which may as noted above fail to sep-
arate strains with a functionally inactive dupA from those
that produce the DupA protein.
Conclusion
Our present study showed that dupA gene was associated
with DU in Chinese population, but its protective effects
against atrophy/gastric cancer could not be confirmed.
Similar to the other virulence factors of H. pylori, regional
differences exist in the distribution of this gene.
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